Synthetic Impurity Profiling
Synthetic Impurity Profiling is a systematic analytical methodology within impurity fate studies that identifies, characterizes, and quantifies structurally defined impurities arising from chemical synthesis pathways, distinguished by its focus on the origin, transformation, and persistence of synthetic by-products in pharmaceutical or chemical manufacturing processes.
23
Publications
616
Citations
136
Authors
52
Institutions
Publications per year
2017–2026
6
23
Caitlyn Norman, Gillian Walker, Brian McKirdy et al. · Drug Testing and Analysis · 2020 · 96 citations · Full text
Joel P. Bercu, Sheila M. Galloway, Patricia Parris et al. · Regulatory Toxicology and Pharmacology · 2018 · 47 citations
1–5 of 23
136
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 136
52

Centre National de la Recherche Scientifique
Paris, France
3 h-index
7 publications
140 citations
Boehringer Ingelheim (United States)
Ridgefield, United States
2 h-index
2 publications
58 citations
Novartis (Switzerland)
Basel, Switzerland
2 h-index
13 publications
167 citations
KU Leuven
Leuven, Belgium
2 h-index
7 publications
117 citations
Eli Lilly (United States)
Indianapolis, United States
2 h-index
9 publications
127 citations

Victoria Police
Docklands, Australia
2 h-index
4 publications
163 citations
AbbVie (United States)
North Chicago, United States
2 h-index
2 publications
58 citations
University of Würzburg
Würzburg, Germany
2 h-index
4 publications
82 citations
1–8 of 52
5 publications · 137 citations
5
h-index
4 publications · 86 citations
4
h-index
4 publications · 57 citations
4
h-index
3 publications · 88 citations
3
h-index
1 publications · 24 citations
1
h-index
1–5